Christianson Mark 4

What Happened
Mark Christianson, Market Development Director at NeuroOne Medical Technologies (NMTC), sold 10,000 shares in an open-market transaction on June 30, 2026. The sale price was $3.18 per share, resulting in proceeds of approximately $31,773. This was a straight sale (S code) and not a purchase or option exercise.

Key Details

• Transaction date: 2026-06-30 (filed on 2026-07-02) — filing appears timely under Form 4 rules.
• Price and amount: 10,000 shares sold at $3.18 each; total proceeds ~$31,773.
• Transaction type: Open-market sale (SEC code S).
• Shares owned after transaction: Not specified in the filing.
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other special footnotes were disclosed in the reported transaction.

Context
Sales by company officers are common and can reflect many reasons (portfolio rebalancing, liquidity needs, etc.); a single open-market sale like this is not in itself a clear signal about company fundamentals. Purchases generally carry more weight as a bullish indicator; this report documents a routine insider sale.